Evidence map›Paper›PMID 25621301›Full record

ArticleOncoscience2014

Cordycepin is a novel chemical suppressor of Epstein-Barr virus replication.

Eunhyun Ryu, Myoungki Son, Minjung Lee, Kanghyo Lee, Jae Youl Cho, Sungchan Cho, Suk Kyeong Lee, You Mie Lee, Hyosun Cho, Gi-Ho Sung and 1 more

Open access · hybridAbstract read
In one paragraph

Article in Oncoscience, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed, 2 pooled it
1.1field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 2 syntheses or guidelines pooled it, 69 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Review
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Review
  11. Medicinal Fungi with Antiviral Effect.Molecules (Basel, Switzerland) · 2022
    Review
  12. Cordycepin: a bioactive metabolite of CJournal of biomolecular structure & dynamics · 2022
    Article
  13. Review
  14. Review
  15. Article
  16. Foods (Basel, Switzerland) · 2021
    Review
  17. Article
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 7 institutions in 1 country.

Eunhyun Ryu *College of Pharmacy and Institute of microorganisms, Kyungpook National University, Daegu, Republic of Korea.
Myoungki Son *College of Pharmacy and Institute of microorganisms, Kyungpook National University, Daegu, Republic of Korea.
Minjung LeeCollege of Pharmacy and Institute of microorganisms, Kyungpook National University, Daegu, Republic of Korea.
Kanghyo LeeMushroom Research Division, National Institute of Horticultural and Herbal Science, Rural Development Administration, Eumseong, Republic of Korea.
Jae Youl ChoDepartment of Genetic Engineering, Sungkyunkwan University, Suwon, Republic of Korea.
Sungchan ChoTargeted Medicine Research Center, Korea Research Institute of Bioscience and Biotechnology, Cheongwon, Chungbuk, Republic of Korea.
Suk Kyeong LeeResearch Institute of Immunobiology, Department of Biomedical Sciences, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.
You Mie LeeCollege of Pharmacy and Institute of microorganisms, Kyungpook National University, Daegu, Republic of Korea.
Hyosun ChoCollege of Pharmacy, Duksung Women's University, Seoul, Republic of Korea.
Gi-Ho SungInstitute for Bio-Medical Convergence, International St. Mary's Hospital, College of Medicine, Catholic Kwangdong University, Incheon, Republic of Korea.
Hyojeung KangCollege of Pharmacy and Institute of microorganisms, Kyungpook National University, Daegu, Republic of Korea.
Kyungpook National University · KRCatholic Kwandong University International St. Mary's Hospital · KRCatholic University of Korea · KRDuksung Women's University · KRKorea Research Institute of Bioscience and Biotechnology · KRRural Development Administration · KRSungkyunkwan University · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cordyceps species are known to produce numerous active components and are used for diverse medicinal purposes because of their varied physiological activities, including their ability to protect the liver from damage as well as their anticancer, antidepressant, anti-inflammatory, hypoglycemic, antimicrobial effects. Cordycepin, an adenosine derivative, differs from adenosine in that its ribose lacks an oxygen atom at the 3' position. Several research groups have reported that cordycepin has antiviral activity against several viruses including influenza virus, plant viruses, human immunodeficiency virus(HIV), murine leukemia virus, and Epstein-Barr virus (EBV). In this study, we identify the epigenetic mechanisms by which cordycepin exerts its anti-gammaherpesvirus effects. We show that cordycepin possesses antitumor and antiviral activity against gastric carcinoma and EBV, respectively. A comparison of the CD50 values of cordycepin and its analogs showed that the lack of a 2'-hydroxyl group in cordycepin was critical for its relatively potent cytotoxicity. Cordycepin treatment decreased the rate of early apoptosis in SNU719 cells by up to 64%, but increased late apoptosis/necrosis by up to 31%. Interestingly, cordycepin increased BCL7A methylation in SNU719 cells by up to 58% and decreased demethylation by up to 37%. Consistent with these changes in methylation, cordycepin treatment significantly downregulated most EBV genes tested. Under the same conditions, cordycepin significantly decreased the frequency of Q and F promoter usage, and H3K4me3 histone enrichment was significantly reduced at several important EBV genomic loci. Extracellular and intracellular EBV genome copy numbers were reduced by up to 55% and 30%, respectively, in response to 125 μM cordycepin treatment. Finally, cordycepin significantly suppressed the transfer of EBV from LCL-EBV-GFP to AGS cells, indicating that EBV infection of gastric epithelial cells was inhibited. These results suggest that cordycepin has antiviral and antitumor activities against gammaherpesviruses and host cells latently infected with virus.

Indexed as

antiviral agentCordycepinEpstein–Barr virusgastric carcinoma

Identifiers

PMID25621301
PMCPMC4303894
OpenAlexW2104094719

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.